Exane Derivatives’s LivaNova LIVN Stock Holding History

Exane Derivatives’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.94K	Hold	47	–	–	﹤0.01%	411
2022 Q1	$3.85K	Hold	47	–	–	﹤0.01%	713
2021 Q4	$2.35K	Hold	47	–	–	﹤0.01%	654
2021 Q3	$2.35K	Hold	47	–	–	﹤0.01%	790
2021 Q2	$2.35K	Hold	47	–	–	﹤0.01%	809
2021 Q1	$3.46K	Hold	47	–	–	﹤0.01%	640
2020 Q4	$2.35K	Hold	47	–	–	﹤0.01%	613
2020 Q3	$2.13K	Hold	47	–	–	﹤0.01%	559
2020 Q2	$2.35K	Hold	47	–	–	﹤0.01%	492
2020 Q1	$2.13K	Hold	47	–	–	﹤0.01%	497
2019 Q4	$2.35K	Hold	47	–	–	﹤0.01%	485
2019 Q3	$2.35K	Hold	47	–	–	﹤0.01%	478
2019 Q2	$2.35K	Hold	47	–	–	﹤0.01%	499
2019 Q1	$2.35K	Hold	47	–	–	﹤0.01%	434
2018 Q4	$2.35K	Hold	47	–	–	﹤0.01%	517
2018 Q3	$2.35K	Hold	47	–	–	﹤0.01%	488
2018 Q2	$2.35K	Hold	47	–	–	﹤0.01%	487
2018 Q1	$2.35K	Hold	47	–	–	﹤0.01%	441
2017 Q4	$2.35K	Sell	47 -3,202	-99%	-$254K	﹤0.01%	449
2017 Q3	$162K	Buy	3,249 +93	+3%	+$5.89K	0.03%	212
2017 Q2	$158K	Buy	3,156 +2,811	+815%	+$159K	0.03%	219
2017 Q1	$16.9K	Hold	345	–	–	﹤0.01%	334
2016 Q4	$15.9K	Hold	345	–	–	﹤0.01%	380
2016 Q3	$20.6K	Hold	345	–	–	﹤0.01%	357
2016 Q2	$17.1K	Hold	345	–	–	﹤0.01%	341
2016 Q1	$18.6K	Hold	345	–	–	﹤0.01%	381
2015 Q4	$223	Buy	+345	New	+$20.9K	﹤0.01%	430

Other funds holding LIVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Exane Derivatives's LIVN Position: Q2 2022 in Review

Exane Derivatives held its LivaNova (LIVN) position steady in Q2 2022 at 47 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #411.

Exane Derivatives first reported a position in LIVN in Q4 2015 and has held it in 27 quarters since. The position peaked at $162K in Q3 2017. 220 funds tracked by Wall St. Rank hold LIVN as of Q2 2022.

Exane Derivatives held 47 shares of LivaNova worth $2.94K as of Q2 2022.
Exane Derivatives left its LivaNova share count unchanged in Q2 2022.
LivaNova made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #411 holding.
Exane Derivatives first reported a position in LivaNova in Q4 2015 and has held it in 27 quarters since.
Exane Derivatives's LivaNova position peaked at $162K in Q3 2017.
220 funds tracked by Wall St. Rank held LivaNova as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.